Rizobacter opened a negotiation process with bond holders of an ON because it cannot pay on the date of the next maturity.

Published Feb 7, 2026

Tridge summary

The Argentine company Rizobacter informed the National Securities Commission (CNV) that it has initiated a negotiation process with holders of the company's Negotiable Bonds (ON) issued in 2023 due to the impossibility of paying the installment due next Tuesday, February 10, 2026, whose nominal amount is 5.07 million dollars. Rizobacter, controlled by Bioceres Crop Solutions, indicated that "it is in talks with holders of said Bonds (Negotiable), considering that, in accordance with the terms of the issuance documents, there is a grace period of thirty days for the fulfillment of its obligations, a period in which the company estimates formalizing a new agreement with the holders through a request for consent". In the latest financial statement presented by the company, it was indicated that "the financial situation of the company (Rizobacter) was unfairly affected by the uncertainty generated by Bioceres S.A...."

Original content

The Argentine company Rizobacter informed the National Securities Commission (CNV) that it has initiated a negotiation process with holders of the company's Negotiable Bonds (ON) issued in 2023 due to the inability to pay the installment due next Tuesday, February 10, 2026, with a nominal amount of 5.07 million dollars. Rizobacter, controlled by Bioceres Crop Solutions, indicated that "it is in talks with holders of said Negotiable Bonds (ON), considering that, in accordance with the terms established in the issuance documents, there is a grace period of thirty days for the fulfillment of its obligations, a period in which the company estimates formalizing a new agreement with the holders through a consent request." In the latest financial statement presented by the company, it was indicated that "the financial situation of the company (Rizobacter) was unfairly affected by the uncertainty generated by Bioceres S.A.–a subsidiary of Bioceres Group Limited and former controlling ...

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.